About Michael Kahana
Michael Kahana is a founder and CEO, director at Nia Therapeutics.
Michael Kahana first appears on SEC filings in 2018.
Experience
This experience comes from Michael Kahana's profile and from SEC filings. For roles taken from filings, the years are when the filings name Michael Kahana in the role, so the role may have started earlier or lasted longer.
Nia Therapeutics, Inc. Current
Founder and CEO, director
Chief Executive Officer (2018 – Present)
2018 – Present · Allston, MA
Develops a brain implant to treat memory loss in people with traumatic brain injuries.
UP
University of Pennsylvania Current
Edmund and Louise Kahn Term Professor of Psychology
2004 – Present
BU
Brandeis University
Assistant to Associate Professor of Psychology
1994 – 2004
Key Colleagues at Startups
The people Michael Kahana works with at each company, as listed on that company's latest Form D.
Nia Therapeutics, Inc. · Form D/A, Jun 3, 2026
Daniel Rizzuto
Founder, President and CTO, director
JW
Jonathan Wachter
Director
Daniel Utin
Chief Software Architect
LG
Larry Greenberg
Director
Milton Morris
Independent Board Director